Nachrichten zur Bristol-Myers Squibb Co Aktie

Bristol Myers Squibb priced 9 international bonds issues in a total amount of USD 19,000m

May 07, 2019 global biopharmaceutical company Bristol Myers Squibb priced 9 international bonds issues in total amount of USD 16,000m.…

Bristol-Myers Squibb Is Selling $19 Billion of Bonds to Buy Celgene

The bond sale is on track to be the biggest so far this year, according to Dealogic data....…

Bristol-Myers Prepares Large Bond Sale To Fund Celgene Purchase

Bristol-Myers Squibb Co. is planning to sell around $20 billion of bonds on Tuesday, seizing on a low-interest rate environment…

Bristol-Myers Squibb And BMS-986036 In NASH: An Update

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Stocks Gets Boost as Analyst Touts Celgene Acquisition

Barclays analyst Geoff Meacham thinks that the companies’ combined drug pipelines make Bristol-Myers a force to watch in the years…

Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Cramer reviews the top activist stories of 2019: eBay, Dollar Tree, Bristol-Myers, Bed Bath & Beyond

"Sometimes, they reach an accommodation with management and it works. Other times they get involved in proxy fights ... and…

2019s top activist stories: eBay, Dollar Tree & more

'Mad Money' host Jim Cramer reviews the best activist stories of this year, including eBay, Dollar Tree, Bristol-Myers and Bed,…

The Zacks Analyst Blog Highlights: FirstEnergy, Synchrony Financial, ExxonMobil, Morgan Stanley and Bristol-Myers

The Zacks Analyst Blog Highlights: FirstEnergy, Synchrony Financial, ExxonMobil, Morgan Stanley and Bristol-Myers...…

Top Research Reports for ExxonMobil, Morgan Stanley & Bristol-Myers

Top Research Reports for ExxonMobil, Morgan Stanley & Bristol-Myers...…

Eliquis Will Continue To Drive Bristol-Myers Squibbs Near Term Earnings Growth

Bristol-Myers Squibb (NYSE:BMY) recently reported its Q1 earnings, and they came in slightly above our estimates, led by margin expansion.…

Bristol-Myers Earnings Call Positive For Celgene Holders

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

3 Reasons Why Growth Investors Shouldnt Overlook Bristol-Myers (BMY)

Bristol-Myers (BMY) is well positioned to outperform the market, as it exhibits above-average growth in financials....…

Bristol-Myers Squibb Company (BMY) CEO Giovanni Caforio on Q1 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Q1 Earnings Beat, Sales Up on Strong Eliquis

Bristol-Myers (BMY) Q1 earnings and sales beat estimates on strong performance of Eliquis and Opdivo....…

Bristol-Myers Squibb Co (BMY) Q1 2019 Earnings Call Transcript

BMY earnings call for the period ending March 31, 2019....…

Bristol-Myers Squibb Posts Solid Q1 Results With the Celgene Acquisition Looming

The big drugmaker beat Wall Street estimates in the first quarter thanks to solid sales growth for its top blockbusters....…

Bristol-Myers Stock Is Rising on Upbeat Earnings Guidance

Bristol-Myers Squibb beat first-quarter expectations by a penny, posting earnings per share of $1.10. And the company is more optimistic…

Bristol-Myers Squibb (BMY) Q1 Earnings and Revenues Top Estimates

Bristol-Myers (BMY) delivered earnings and revenue surprises of 0.92% and 2.09%, respectively, for the quarter ended March 2019. Do the…

US-Pharmakonzern Bristol-Myers Squibb startet stark ins neue Jahr

NEW YORK (dpa-AFX) - Der Pharmakonzern Bristol-Myers Squibb (BMS) (Bristol-Myers Squibb) hat seinen Umsatz zum Jahresbeginn deutlich gesteigert. Vor allem…

The Daily Biotech Pulse: Adverum Gets New CFO, Flexions Osteoarthritis Trial, Bristol-Myers Earnings

Heres a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit…

US-Pharmakonzern Bristol-Myers Squibb startet stark ins neue Jahr

NEW YORK (dpa-AFX) - Der Pharmakonzern Bristol-Myers Squibb (BMS) hat seinen Umsatz zum Jahresbeginn deutlich…

Bristol-Myers sales beat estimates, driven by its blockbuster blood thinner

Um den gesamten Artikel unter bloom.bg zu lesen, klicken Sie bitte auf die Überschrift...…

Key Drugs Lift Bristol-Myers Results Ahead of Celgene Deal

Bristol-Myers Squibb said its first-quarter profit and revenue rose on stronger demand for its key drugs, as the company looks…

Bristols Opdivo, Eliquis lift results

Bristol-Myers Squibb Co. said its first-quarter profit and revenue rose on stronger demand for its key drugs, as the company…

Bristol-Myers profit slightly tops Wall Street view on blood thinner sales

U.S drugmaker Bristol-Myers Squibb Co, which is set to buy biotechnology company Celgene Corp for $74 billion, posted slightly better-than-expected…

Bristol-Myers Tops Q1 Earnings Estimate After Winning Celgene Takeover Approval

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

Bristol-Myers Squibb und Celgene: Der Fahrplan für die Übernahme

Die Übernahme wird kommen. Doch sollte man mitgehen?...…

Bristol-Myers Squibb Expected to Earn $1.09 a Share

Um den gesamten Artikel unter thestreet.com zu lesen, klicken Sie bitte auf die Überschrift...…

What To Expect From Bristol-Myers Squibb In Q1-

Bristol-Myers Squibb (NYSE:BMY) is expected to publish its Q1 2019 results on April 25. This note details Trefis forecasts for…

AbbVie and Bristol-Myers Squibb will report first-quarter earnings on Thursday. Here’s what to expect

Here’s what investors should look for on Thursday as these two pharmaceutical giants report first-quarter earnings....…

What to Watch for in Bristol-Myers Squibb Earnings

Bristol-Myers Squibb stock is down 13% this year, partly because investors have been skeptical of its move to buy biotech…

Will Bristol-Myers (BMY) Disappoint This Earnings Season-

Performance of Opdivo and the impending acquisition of Celgene Corporation will be key areas of focus for the investors, when…

How Marijuana Legalization Affected OrganiGram and Aphrias Latest Results

These two marijuana stocks reported very different results last quarter. Plus, how Abbotts challenging Dexcom in diabetes, and whats next…

Why Celgene Shareholders Should Hold On to Their Bristol-Myers Squibb Stock Once the Acquisition Closes

The fat lady is getting ready to sing with this big pharma deal. Celgene shareholders will soon have a decision…

Bristol-Myers Shareholders Vote for Celgene Acquisition

Bristol-Myers (BMY) gets a green signal from a majority of its shareholders for the merger with Celgene Corporation....…

One step closer to creating that great company with Celgene, says Bristol-Myers CEO

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said....…

Bristol-Myers CEO: Were one step closer to creating that great company with Celgene

Celgene brings to Bristol-Myers five late-stage products that could be approved in the near term, Caforio said....…

UPDATE 2-Bristol-Myers says shareholders vote to approve Celgene takeover

Bristol-Myers Squibb Cos shareholders voted to approve the drugmakers $74 billion acquisition of biotech Celgene Corp on Friday despite a campaign by activist…

Bristol-Myers Shareholders Approve $74 Billion Deal For Celgene

Bristol-Myers shareholders voted to approve the $74 billion acquisition of Celgene, a combination that creates a cancer drug powerhouse with…

Dispensed: Pharma middlemen get their day in the hot seat, life at Flatiron Health a year after acquisition, and almost $1 billion invested in clinical trial startups

Hello, Well, its official: Bristol-Myers Squibb and Celgene are likely going to form the megamerger of their dreams, after shareholders approved…